The Journal of Pediatrics
Volume 151, Issue 3 , Pages 232-234 , September 2007

Specific Immune Globulin Therapy for Prevention of Nosocomial Staphylococcal Bloodstream Infection in Premature Infants: Not What We Hoped for!

  • M. Teresa de la Morena, MD

      Affiliations

    • Corresponding Author InformationReprint requests: M. Teresa de la Morena, MD, Division of Allergy and Immunology, University of Texas Southwestern Medical Center in Dallas, 1935 Motor St, Dallas, TX 75235.

References 

  1. Callaghan WM, MacDorman MF, Rasmussen SA, Qin C, Lackritz EM. The contribution of preterm birth to infant mortality rates in the United States. Pediatrics. 2006;118:1566–1573
  2. DeJonge M, Bloom BD, et al. Phase III, randomized, double-blind, placebo-controlled multi-center clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal sepsis in premature infants. J Pediatr. 2007;151:260–265
  3. Stoll BJ, Hansen N. Infections in VLBW infants: studies from the NICHD Neonatal Research Network. Semin Perinatol. 2003;27:293–301
  4. Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR, et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr. 1996;129:63–71
  5. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110(Pt 1):285–291
  6. In:  Behrman RE,  Butler AS editor. Committee on Understanding Premature Birth and Assuring Healthy Outcomes, Board on Health Science Policy, Institute of Medicine. Preterm Births: Causes, Consequences, and Prevention. 2006;Brief Report July. http://www.iom.edu/object.file/Master/35/975/pretermbirth.pdf. Accessed August 8s, 2007
  7. Baker CJ, Melish ME, Hall RT, Casto DT, Vasan U, Givner LB. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates (The Multicenter Group for the Study of Immune Globulin in Neonates). N Engl J Med. 1992;327:213–219
  8. Weisman LE, Stoll BJ, Kueser TJ, Rubio TT, Frank CG, Heiman HS, et al. Intravenous immune globulin prophylaxis of late-onset sepsis in premature neonates. J Pediatr. 1994;125(Pt 1):922–930
  9. Fanaroff AA, Korones SB, Wright LL, Wright EC, Poland RL, Bauer CB, et al. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants (National Institute of Child Health and Human Development Neonatal Research Network). N Engl J Med. 1994;330:1107–1113
  10. Ohlsson A, Lacy JB. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database Syst Rev. 2004;1:CD001239
  11. The PREVENT Study Group. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics. 1997;99:93–99
  12. Bloom B, Schelonka R, Kueser T, Walker W, Jung E, Kaufman D, et al. Multicenter study to assess safety and efficacy of INH-A21, a donor-selected human staphylococcal immunoglobulin, for prevention of nosocomial infections in very low birth weight infants. Pediatr Infect Dis J. 2005;24:858–866
  13. Bona C. Neonatal immunity. In:  Rose NR editors. Contemporary immunology. Totowa, NJ: Humana Press; 2005;p. 1–389
  14. Ballow M, Cates KL, Rowe JC, Goetz C, Desbonnet C. Development of the immune system in very low birth weight (less than 1500 g) premature infants: concentrations of plasma immunoglobulins and patterns of infections. Pediatr Res. 1986;20:899–904
  15. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, et al. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science. 1999;286(5439):525–528
  16. Yoshio H, Tollin M, Gudmundsson GH, Lagercrantz H, Jornvall H, Marchini G, et al. Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense. Pediatr Res. 2003;53:211–216
  17. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002;347:1151–1160
  18. Murakami M, Ohtake T, Dorschner RA, Schittek B, Garbe C, Gallo RL. Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J Invest Dermatol. 2002;119:1090–1095
  19. Komatsuzawa H, Ouhara K, Yamada S, Fujiwara T, Sayama K, Hashimoto K, et al. Innate defenses against methicillin-resistant Staphylococcus aureus (MRSA) infection. J Pathol. 2006;208:249–260

PII: S0022-3476(07)00603-8

doi: 10.1016/j.jpeds.2007.06.031

The Journal of Pediatrics
Volume 151, Issue 3 , Pages 232-234 , September 2007

Article Tools